Additionally, TLR9 engagement increases the number of CD4+ and CD8+ T cells by boosting the expression of IL-2 and of its associated receptor IL-12R, which takes place even in the absence of costimulatory molecules (such as CD28) in a tumor microenvironment [196]. Here, CD4 is linked to neoplasm.